Drug Design, Development and Therapy
Zero Events, Limited Precision, and the Interpretation of Olanzapine Safety in Patients with Diabetes Receiving Cisplatin [Letter]
By Shen S and Wang Z.
Abstract
Shiying Shen,1 Zhenrong Wang2,31School of Public Health and Nursing, Hangzhou Normal University, Hangzhou, People’s Republic of China; 2Department of Pulmonary and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, People’s Republic of China; 3State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital, Sichuan University, Chengdu, Sichuan, People’s Republic of ChinaCorrespondence: Zhenrong Wang, Department of Pulmonary and Critical Care Medicine, West China Hospital, Sichuan University, No. 37, Guoxue Alley, Wuhou District, Chengdu, Sichuan, 610041, People’s Republic of China, Tel +86 18215523687, Email zhenrongwang1993@wchscu.cn